Guru Ownership Trend
Guru Analysis for Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $327.07 M.
Top institutional holders include Catherine Wood and Renaissance Technologies.
Institutional sentiment is currently Bullish. This is evidenced by a $44.43 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies who opened a new position. Conversely, Murray Stahl reduced exposure by 4.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Beam Therapeutics Inc. (BEAM)
Major holders include Catherine Wood ($345.59 M), Renaissance Technologies ($4.34 M), Paul Tudor Jones ($449,258). According to the latest reported data, 5 tracked investment managers collectively hold approximately 12.66 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $44.43 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited BEAM. The total reported sell value was $11,171.13.
Yes, 2 managers opened new positions in BEAM, and 2 increased their existing holdings. The total reported buy value was $44.44 M.